Katherine has close to 4 years of experience working for two Canadian public payers where she built extensive knowledge regarding public drug plans as well as the interplay with the overall pharmaceutical landscape. Her roles in both New Brunswick and Alberta supported public payer decision making and she was an active participant in pan-Canadian Pharmaceutical Alliance (pCPA) operations. She has led and supported numerous pCPA negotiations and subsequent product listing agreement implementation in both provinces. She was integral to the development and implementation of multiple policy initiatives, including the Alberta Biosimilar Initiative. Katherine’s background in economics, along with her experience with two public drug plans and the pCPA provide a unique and valuable perspective when working towards market access solutions.
Katherine Scott
Developing strategies that consider the challenges and perspective of the public payer is crucial to achieving success in the Canadian market. I am eager to support clients by applying my distinct frame of reference to the increasingly complex and ever evolving market landscape.
As a Senior Consultant, Katherine supports MORSE’s clients by providing public payer and pCPA insights to inform the development of their overall reimbursement strategy, including pCPA assessments, advisory board participation and simulated pCPA negotiation services.
Katherine can be reached at Katherine@morseconsulting.ca or 204-720-1174.
MORSE Consulting Inc. | Deciphering Canadian pharmaceutical market access signals to create reimbursement success.
© 2023 MORSE Consulting Inc. All rights reserved. |
Site by Directica Media
Katherine Scott, Consultant at MORSE Consulting Inc.